Rutschmann OT - Search Results

1

Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.

Rutschmann OT, Negro F, Hirschel B, Hadengue A, Anwar D, Perrin LH. Rutschmann OT, et al. J Infect Dis. 1998 Mar;177(3):783-5. doi: 10.1086/517808. J Infect Dis. 1998. PMID: 9498464 Clinical Trial.

2

Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study.

Lorenzi P, Yerly S, Abderrakim K, Fathi M, Rutschmann OT, von Overbeck J, Leduc D, Perrin L, Hirschel B. Lorenzi P, et al. Among authors: rutschmann ot. AIDS. 1997 Oct;11(12):F95-9. doi: 10.1097/00002030-199712000-00002. AIDS. 1997. PMID: 9342060 Clinical Trial.

3

Cell-associated HIV-1 RNA in blood as indicator of virus load in lymph nodes. The Swiss HIV Cohort Study.

Yerly S, Rutschmann OT, Opravil M, Marchal F, Hirschel B, Perrin L. Yerly S, et al. Among authors: rutschmann ot. J Infect Dis. 1999 Sep;180(3):850-3. doi: 10.1086/314932. J Infect Dis. 1999. PMID: 10438378 Clinical Trial.

4

Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study.

Rutschmann OT, Opravil M, Iten A, Malinverni R, Vernazza PL, Bucher H, Bernasconi E, Perrin LH, Yerly S, Hirschel B. Rutschmann OT, et al. Antivir Ther. 1998;3 Suppl 4:65-7. Antivir Ther. 1998. PMID: 10723515 Clinical Trial.

5

Antiretroviral therapy: a guide to the most important trials.

Rutschmann O, Hirschel B. Rutschmann O, et al. Schweiz Med Wochenschr. 1997 Mar 15;127(11):436-43. Schweiz Med Wochenschr. 1997. PMID: 9098917 Review.

6

Regression of Kaposi's sarcoma during therapy with HIV-1 protease inhibitors: a prospective pilot study.

Krischer J, Rutschmann O, Hirschel B, Vollenweider-Roten S, Saurat JH, Pechère M. Krischer J, et al. J Am Acad Dermatol. 1998 Apr;38(4):594-8. doi: 10.1016/s0190-9622(98)70124-0. J Am Acad Dermatol. 1998. PMID: 9555800

7

A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study.

Rutschmann OT, Opravil M, Iten A, Malinverni R, Vernazza PL, Bucher HC, Bernasconi E, Sudre P, Leduc D, Yerly S, Perrin LH, Hirschel B. Rutschmann OT, et al. AIDS. 1998 May 28;12(8):F71-7. doi: 10.1097/00002030-199808000-00003. AIDS. 1998. PMID: 9631134 Clinical Trial.

8

Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study.

Rutschmann OT, Vernazza PL, Bucher HC, Opravil M, Ledergerber B, Telenti A, Malinverni R, Bernasconi E, Fagard C, Leduc D, Perrin L, Hirschel B. Rutschmann OT, et al. AIDS. 2000 Sep 29;14(14):2145-51. doi: 10.1097/00002030-200009290-00011. AIDS. 2000. PMID: 11061656 Clinical Trial.

9

Adding saquinavir to stavudine in patients with advanced HIV-1 infection.

Rutschmann OT, Kaiser L, Perrin L, Fathi M, Hirschel BJ. Rutschmann OT, et al. AIDS. 1997 Mar 15;11(4):548. AIDS. 1997. PMID: 9084811 No abstract available.

10

Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort.

Morawetz RA, Rizzardi GP, Glauser D, Rutschmann O, Hirschel B, Perrin L, Opravil M, Flepp M, von Overbeck J, Glauser MP, Ghezzi S, Vicenzi E, Poli G, Lazzarin A, Pantaleo G. Morawetz RA, et al. Eur J Immunol. 1997 Dec;27(12):3223-7. doi: 10.1002/eji.1830271220. Eur J Immunol. 1997. PMID: 9464809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters